Atypical antipsychotics: Special formulations for acute agitation

Journal of Psychosocial Nursing and Mental Health Services

Volumn 43, Issue 10, 2005, Pages 14-17

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27144522605     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Allen, M.H., & Currier, G.W. (2004). Use of restraints and pharmacotherapy in academic psychiatric emergency services. General Hospital Psychiatry, 26, 42-49.
2. Allen, M.H., Currier, G.W., Hughes, D.H., Docherty, J.P., Carpenter, D., & Ross, R. (2003). Treatment of behavioral emergencies: A summary of the expert consensus guidelines. Journal of Psychiatric Practice, 9(1), 16-38.
3. Brier, A., Meehan, K., Birkett, M., David, S., Ferchland, I., Sutton, V., et al. (2002). A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Archives of General Psychiatry, 59, 441-448.
4. Brook, S. (2003). Intramuscular ziprasidone: Moving beyond the conventional in the treatment of acute agitation in schizophrenia. Journal of Clinical Psychiatry, 64(Suppl. 19), 13-18.
5. Brook, S., Lucey, J.V., Gunn, K.P., & Ziprasidone IM Study Group. (2000). Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Journal of Clinical Psychiatry, 61, 933-941.
6. Brook, S., Walden, J., Benattia, I., Siu, C.O., & Romano, S.J. (2005). Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: Comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology, 178, 514-523.
7. Chue, P., Welch, R., & Binder, C. (2004). Acceptability and disintegration rates of orally disintegrating risperidone tablets in patients with schizophrenia or schizoaffective disorder. Canadian Journal of Psychiatry, 49, 701-703.
8. Currier, G.W., & Simpson, G.M. (2001). Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. Journal of Clinical Psychiatry, 62, 153-157.
9. Daniel, D.G., Potkin, S.G., Reeves, K.R., Swift, R.H., & Harrigan, E.P. (2001). Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: A double-blind, randomized trial. Psychopharmacology, 155, 128-134.
10. Daniel, D.G., Zimbroff, D.L., Swift, R.H., & Harrigan, E.P. (2004). The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy. International Clinical Psychopharmacology, 19, 9-15.
11. Gismondi, R., Daniel, D., Stock, E., Wilbur, R., Marcus, R., Carson, W., et al. (2004). Intramuscular aripiprazole treatment for acute agitation in patients with psychosis. Neuropsychopharmacology, 14(Suppl. 3), S261.
12. Greco, K.E., Tune, L.E., Brown, F.W., & Van Horn, W.A. (2005). A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients. Journal of Clinical Psychiatry, 66, 928-929.
13. Kinon, B.J., Hill, A.L., Liu, H., & Kollack-Walker, S. (2003). Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia. International Journal of Neuropsychopharmacology, 6(2), 97-102.
14. Lesem, M.D., Zajecka, J.M., Swift, R.H., Reeves, K.R., & Harrigan, E.P. (2001). Intramuscular ziprasidone, 2 mg vs. 10 mg, in the short-term management of agitated psychotic patients. Journal of Clinical Psychiatry, 62, 12-18.
15. Lindborg, S.R., Beasley, C.M., Alaka, K., & Taylor, C.C. (2003). Effects of intramuscular olanzapine vs. haloperidol and placebo on QTC intervals in acutely agitated patients. Psychiatry Research, 119, 113-123.
16. Meehan, K.M., Wang, H., David, S.R., Nisivoccia, J.R., Jones, B., Beasley, C.M., et al. (2002). Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: A double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology, 26, 494-504.
17. Meehan, K., Zhang, F., David, S., Tohen, M., Janicak, P., Small, J., et al. (2001). A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. Journal of Clinical Psychopharmacology, 21, 389-397.
18. Oren, D., Iwamoto, T., Marcus, R., Vanveggel, S., McQuade, R., Stock, E., et al. (2005, May). Intramuscular aripiprazole versus placebo for agitation in acute mania. Poster presented at the annual meeting of the American Psychiatric Association, Atlanta, GA.
19. Pereira, A., Boulton, D., Dressler, D., Kollia, G., Carlson, B., Crandall, D., et al. (2005, March). Aripiprazole bioequivalence: Orally disintegrating tablet compared to tablet formulation. Poster presented at the annual meeting of the College of Psychiatric and Neurologic Pharmacists, San Diego, CA.
20. Preval, H., Klotz, S.G., Southard, R., & Francis, A. (2005). Rapid-acting IM ziprasidone in a psychiatric emergency service: A naturalistic study. General Hospital Psychiatry, 27, 140-144.
21. Wright, P., Birkett, M., David, S.R., Meehan, K., Ferchland, I., Alaka, K.J., et al. (2001). Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. American Journal of Psychiatry, 158, 1149-1151.
22. Wright, P., Meehan, K., Birkett, M., Lindborg, S.R., Taylor, C.C., Morris, P., et al. (2003). A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clinical Therapeutics, 25, 1420-1428.
23. Yocca, F., Marcus, R., Oren, D., Manos, G., Carson, W.H., Iwamoto, T., et al. (2005, May). Intramuscular aripiprazole in acute schizophrenia: A pivotal phase-three study. Poster presented at the annual meeting of the American Psychiatric Association, Atlanta, GA.